NASDAQ: SLN - Silence Therapeutics plc

छह महीने के लिए लाभप्रदता: -18.71%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Silence Therapeutics plc

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's mRNAi GOLD GalNAc Oligonucleotide Discovery platform that is used to target specific disease-associated genes in the liver. Its siRNA molecules to harness the body's natural mechanism of RNA interference, and degrading messenger RNA molecules that encode specific targeted disease-associated proteins in a cell.

अधिक जानकारी
The company develops SLN360, which is in phase 2 clinical development to reduce high levels of lipoprotein; SLN124 that is in Phase I clinical trials for the treatment of non-transfusion dependent thalassemia, and Phase I clinical trials for the treatment of myelodysplastic syndrome; and polycythemia vera. It has collaboration agreements with AstraZeneca PLC to discover, develop, and commercialize small interfering siRNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; Hansoh Pharmaceutical Group Company Limited to develop siRNAs for three undisclosed targets leveraging Silence's mRNAi GOLD platform, as well as the company also collab with Mallinckrodt Pharma IP Trading DAC to develop and commercialize RNAi drug targets designed to silence the complement cascade in complement-mediated disorders. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, the United Kingdom.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

Выручка 0.000244
EBITDA -0.0222
Число акций ао 0.03709 млрд
P/S 81.28
P/BV 49.16
EV/EBITDA 0.5952
Цена ао 19.27
ISIN US82686Q1013
Сайт https://www.silence-therapeutics.com
Валюта usd
IPO date 2020-09-08
Sector Health Care
Industry Biotechnology
Валюта отчета gbp
प्रति दिन मूल्य परिवर्तन: 0% (18.29)
प्रति सप्ताह मूल्य परिवर्तन: -5.23% (19.3)
प्रति माह मूल्य परिवर्तन: +0.3291% (18.23)
3 महीने में कीमत में बदलाव: -11.51% (20.67)
छह महीने में कीमत में बदलाव: -18.71% (22.5)
प्रति वर्ष मूल्य परिवर्तन: +147.83% (7.38)
3 वर्षों में मूल्य परिवर्तन: -13.24% (21.08)
वर्ष की शुरुआत से मूल्य परिवर्तन: +58.35% (11.55)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 19.51 1
P/BV 29.03 1
P/E 0 0
EV/EBITDA -9.26 0
कुल: 3.13

क्षमता

नाम अर्थ श्रेणी
ROA, % -46.12 0
ROE, % -253.77 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.0057 10
कुल: 9.6

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 10299.59 10
लाभप्रदता Ebitda, % 114.44 10
लाभप्रदता EPS, % 241.07 10
कुल: 8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Lombard Odier Asset Management (USA) Corp 3879173 12.96
Lombard Odier Asset Management (Europe) Ltd 3612877 12.07
Artal Group S.A. 3000000 10.02
Tcg Crossover Management, Llc 2104875 7.03
Deep Track Capital, LP 1951580 6.52
BVF Inc. 1508416 5.04
Aquilo Capital Management, LLC 1043284 3.49
Frazier Life Sciences Management, L.P. 881173 2.94
Vivo Capital, LLC 510204 1.7
Logos Global Management LP 400000 1.34

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
Virtus LifeSci Biotech Clinical Trials ETF 0.73377 63.040315712071 0.33
SPDR Portfolio MSCI Global Stock Market ETF 0 23.658352229781 2.19607



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Craig A. Tooman M.B.A. President, CEO & Executive Director 1.49M 1965 (59 साल)
Ms. Rhonda L. Hellums Executive VP, CFO & Secretary 907.23k 1972 (52 वर्ष)
Dr. Steven J. Romano M.D. Executive VP and Chief Research & Development Officer 662.65k 1959 (65 साल)
Dr. Marie Wikstrom Lindholm Ph.D. Chief Scientific Officer N/A
Ms. Gem Gokmen Hopkins Head of IR & Corporate Communications N/A
Dr. Barbara A. Ruskin J.D., Ph.D. Senior VP and Chief Intellectual Property & Innovation Officer N/A 1960 (64 वर्ष)
Dr. Eric Floyd M.B.A., M.S., Ph.D. Senior Vice President of Regulatory Affairs & Quality Assurance N/A 1963 (61 वर्ष)
Mr. J.P. Gabriel Chief Technical Operations Officer N/A
Mr. Curtis Rambaran M.D. Chief Medical Officer N/A
Ms. Gianine Esposito Chief Human Resources Officer

पता: United Kingdom, London, 72 Hammersmith Road - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.silence-therapeutics.com